Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia
Taeko Kaburagi(Gunma University), Yasuhide Hayashi(Gunma Children's Medical Center), Keizo Horibe(National Hospital Organization), Manabu Sotomatsu(Gunma Children's Medical Center), Daisuke Tomizawa(National Center For Child Health and Development), Yuichi Shiraishi(The University of Tokyo), Kenichi Yoshida(Kyoto University), Takashi Taga(Erasmus MC), Norio Shiba(Gunma University), H. Matsuo(Kyoto University), Kentaro Ohki(National Center For Child Health and Development), Seishi Ogawa(Keio University), Genki Yamato(Gunma University), Souichi Adachi(Kyoto University), Nobutaka Kiyokawa(National Center For Child Health and Development), Hirokazu Arakawa(Institute of Molecular and Cell Biology), Ken Tabuchi, Tomohiko Taki(Kyorin University), Satoru Miyano(Cardiovascular Institute Hospital), Akira Shimada(Tohoku University), Yusuke Hara(Kitasato University)
Cited by 37
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478
International consensus on (ICON) pediatric asthma
|Allergy|2012|462